Granules India promoter sells 1.72 crore shares in block deal

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Promoter Dr. Krishna Prasad Chigurupati sold 1,72,00,000 shares via block deal on September 11, 2026
  • Stake reduced from 31.00% to 24.06% of total voting capital
  • Institutional buyers included Capital Group, Kotak Life, and ChrysCapital
  • Post-sale holding stands at 5,96,08,111 shares (21.85% diluted)
powered bylight_fuzz_icon
50739581

*this image is generated using AI for illustrative purposes only.

Granules India Limited promoter Dr. Krishna Prasad Chigurupati disposed of 1,72,00,000 equity shares through a block deal on September 11, 2026. The transaction represented 6.94% of the company’s total voting capital.

The sale reduced Chigurupati’s stake in the Hyderabad-based pharmaceutical firm from 31.00% to 24.06%. Prior to the transaction, he held 7,68,08,111 shares carrying voting rights.

Transaction Details

The block deal saw participation from marquee institutional investors. Buyers included Capital Group, Kotak Mahindra Life Insurance Company, ChrysCapital, Allspring, and other domestic and global entities.

Metric Before Sale Shares Sold After Sale
Shares Held 7,68,08,111 1,72,00,000 5,96,08,111
Stake (% of Voting Capital) 31.00% 6.94% 24.06%
Diluted Stake (%) 28.16% 6.31% 21.85%

Chigurupati filed the disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The filing was submitted to the National Stock Exchange of India Limited and BSE Limited.

What the Numbers Show

The promoter’s post-transaction holding of 5,96,08,111 shares represents a significant reduction in concentration risk for institutional buyers. While the absolute stake dropped by nearly seven percentage points, Chigurupati retains control with a diluted holding of 21.85%, remaining the largest single shareholder group as no other entity was disclosed as acquiring a controlling interest in this specific transaction.

Historical Stock Returns for Granules

1 Day5 Days1 Month6 Months1 Year5 Years
+1.12%+6.49%+6.33%+56.43%+73.32%0.0%

How might the entry of marquee institutional investors like Capital Group and Allspring influence Granules India's corporate governance and strategic decision-making?

What are the potential implications for Granules India's stock price volatility given the significant reduction in promoter concentration risk?

Could this block deal signal the promoter's intent to raise capital for future acquisitions or debt reduction, and how might that impact the company's balance sheet?

Granules India hosts analyst meet on September 18 in Hyderabad

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Granules India hosts analyst meet on September 18, 2026
  • Session held in Hyderabad per SEBI LODR Regulation 30
  • No unpublished price-sensitive info to be shared
  • Schedule is tentative and subject to change
powered bylight_fuzz_icon
50669068

*this image is generated using AI for illustrative purposes only.

Granules India Limited will host a meeting with analysts, investors, and funds in Hyderabad on September 18, 2026. The session is part of the company's regular engagement with the investment community.

The announcement was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Chaitanya Tummala, Company Secretary and Compliance Officer, confirmed the schedule on September 11, 2026.

Meeting Details

The management team will address queries from the investment community. The company stated that no unpublished price-sensitive information (UPSI) is proposed to be shared during the meeting.

The schedule remains tentative and may be subject to changes due to difficulties faced by the company or the participants. Investors seeking updated financial information can access the latest investor presentation on the company’s website.

Regulatory Compliance

Granules India Limited is listed on both the National Stock Exchange of India Limited and BSE Limited. The disclosure ensures transparency and equal access to information for all stakeholders as mandated by securities regulations.

Historical Stock Returns for Granules

1 Day5 Days1 Month6 Months1 Year5 Years
+1.12%+6.49%+6.33%+56.43%+73.32%0.0%

How might the management's responses to investor queries during this meeting influence Granules India's stock valuation in the near term?

What specific strategic initiatives or pipeline developments is the company likely to emphasize to attract institutional funds given the current pharma market climate?

Could this engagement signal an upcoming material corporate action, such as a rights issue or dividend revision, despite the disclaimer on unpublished price-sensitive information?

More News on Granules

1 Year Returns:+73.32%